+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma), and Region - Forecast to 2027

  • PDF Icon

    Report

  • 270 Pages
  • May 2022
  • Region: Global
  • Markets and Markets
  • ID: 4520321

Growing Opportunities for CMOs and CDMOs

The global HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others.



The innovative HPAPIs segment is expected to account for the largest share of the market in 2021


Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments.

The Synthetic APIs segment to account for the largest share of the market in 2021


Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic APIs segment is expected to command the largest share in 2021. Ease of production and emergence of new molecules and technological advancements in synthesis are driving growth of synthetic HPAPI segment.

The Oncology segment is expected to account for the largest share of the market in 2021


Based on therapeutic application, the market is divided into oncology, hormonal imbalance, glaucoma, and other therapeutic applications. In 2021, Oncology segment is expected to account for the largest share in the market. The launch of new target therapies in addition to technological advancements and growing prevalence of cancer across the globe are driving growth of oncology segment.

Asia is the fastest growing region of HPAPI market from 2022 to 2027


HPAPI market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia to grow at the highest CAGR during the forecast period. High prevalence of chronic diseases, lifestyle diseases, age related diseases and government efforts for encouragement for the adoption of generics are some of the factors driving the growth of the market in Asia.


Research Coverage


The report segments the HPAPI market based on region (Asia, Europe, North America, and RoW), Type (Innovative, Generic), Type of Synthesis (Biotech, Synthetic), Type of manufacturer (Captive and Merchant), Therapeutic Applications (Oncology, Hormonal Imbalance, Glaucoma). The report also provides a comprehensive review of market drivers, opportunities, restraints, and challenges in the HPAPI market.

Prominent players in the HPAPI market include Pfizer, Inc. (US), F. Hoffmann-La Roche (Switzerland), Sanofi (France), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Novartis International AG (Switzerland), Boehringer Ingelheim International GmbH (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (US), Merck & Co., Inc. (US), AbbVie (US), and Viatris Inc. (US).


Breakdown of Primaries


The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
  • By Respondent: Supply Side: 70% and Demand Side: 30%
  • By Designation: Managers: 65%, Executives: 25%, and CXOs: 10%
  • By Region: North America: 25%, Europe: 20%, Asia: 45%, and RoW: 10%

Key Benefits of Buying the Report


The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall HPAPI market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.
Frequently Asked Questions about the Global High Potency APIs/HPAPI Market

What is the estimated value of the Global High Potency APIs/HPAPI Market?

The Global High Potency APIs/HPAPI Market was estimated to be valued at $24.5 Billion in 2022.

What is the growth rate of the Global High Potency APIs/HPAPI Market?

The growth rate of the Global High Potency APIs/HPAPI Market is 10.1%, with an estimated value of $39.6 Billion by 2027.

What is the forecasted size of the Global High Potency APIs/HPAPI Market?

The Global High Potency APIs/HPAPI Market is estimated to be worth $39.6 Billion by 2027.

Who are the key companies in the Global High Potency APIs/HPAPI Market?

Key companies in the Global High Potency APIs/HPAPI Market include AbbVie Inc., Bayer, Boehringer, Ingelheim, Bristol, Myers Squibb Company, Eli Lily and Company, F. Hoffmann and Merck & Co. Inc..

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Years Considered
1.4 Currency
1.5 Limitations
1.6 Summary of Changes
1.7 Stakeholders
2 Research Methodology
2.1 Secondary Data
2.1.1 Secondary Sources
2.2 Primary Data
2.2.1 Key Data from Primaries
2.2.2 Primary Insights
2.3 Market Size Estimation
2.4 Market Growth Rate Projections
2.5 Market Breakdown and Data Triangulation
2.6 Research Assumptions
2.7 Risk Analysis
3 Executive Summary
4 Premium Insights
4.1 HPAPI: Market Overview
4.2 HPAPI Market, by Type, 2021 vs. 2027 (USD Billion)
4.3 HPAPI Market, by Type of Synthesis, 2021 vs. 2027 (USD Billion)
4.4 HPAPI Market by Therapeutic Area (2021-2027)
4.5 Geographical Snapshot of HPAPI Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Demand for Oncology Drugs
5.2.1.2 Growing Demand for Antibody-Drug Conjugates
5.2.1.3 Increasing Focus of Leading Pharmaceutical Companies on HPAPIs
5.2.1.4 Advancements in HPAPI Manufacturing Technologies
5.2.1.5 Growing Focus on Precision Medicine
5.2.2 Restraints
5.2.2.1 Increasing Requirement of Large Investments for Employee Safety
5.2.2.2 Discrepancies in HPAPI Banding Systems
5.2.2.3 Rising Number of Uncertainties Associated with Products
5.2.2.4 High Risk of Cross-Contamination
5.2.3 Opportunities
5.2.3.1 Growing Opportunities for CMOs and CDMOs
5.2.3.2 Increasing Opportunities for Companies in Emerging Markets
5.2.4 Challenges
5.2.4.1 Need for Appropriate Process Designs
5.2.4.2 Constant Evolution of Industry Standards and Technologies
5.3 Impact of COVID-19 on HPAPI Market
5.4 Regulatory Analysis
5.4.1 Handling HPAPI
5.4.2 Third Party Certification
5.4.3 Containment Strategies
5.4.4 Challenges
5.5 Porter's Five Forces Analysis
5.5.1 Threat of New Entrants
5.5.2 Threat of Substitutes
5.5.3 Bargaining Power of Suppliers
5.5.4 Bargaining Power of Buyers
5.5.5 Degree of Competition
5.6 Technology Analysis
5.6.1 Handling Potent Compounds
5.6.2 Controls
5.6.3 Safety Assessment and Standard Operating Procedures
5.6.4 Dedicated Equipment and Systems
5.6.5 Expertise and Training
5.6.6 Combustible Dust Handling
5.6.7 Suitable Personal Protective Equipment
6 High-Potency Active Pharmaceutical Ingredients Classification and Overview
6.1 Introduction
6.2 HPAPI Ingredients Classification as Per Safebridge Consultants
7 HPAPI Market, by Type
7.1 Introduction
7.2 Innovative HPAPIs
7.3 Generic HPAPIs
8 HPAPI Market, by Type of Synthesis
8.1 Introduction
8.2 Synthetic APIs
8.2.1 Synthetic APIs Market, by Type
8.3 Biotech APIs
8.3.1 Biotech APIs Market, by Type
8.3.2 Biotech APIs Market, by Product
8.3.3 Vaccines
8.3.4 Recombinant Proteins
9 HPAPI Market, by Type of Manufacturer
9.1 Introduction
9.2 Captive HPAPI Manufacturers
9.3 Merchant HPAPI Manufacturers
9.3.1 Merchant HPAPI Manufacturers Market, by Type
9.3.2 Merchant HPAPI Manufacturers Market, by Type of Synthesis
9.3.3 Synthetic APIs
9.3.4 Biotech APIs
10 HPAPI Market, by Therapeutic Application
10.1 Introduction
10.2 Oncology
10.3 Hormonal Imbalance
10.4 Glaucoma
10.5 Other Therapeutic Applications
11 HPAPI Market, by Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 UK
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia
11.5 Rest of the World
12 Competitive Landscape
12.1 Overview
12.2 Key Players Strategies/Right to Win
12.3 Market Share Analysis
12.4 Revenue Share Analysis of the Top Market Players
12.5 Company Evaluation Quadrant
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.6 Footprint of Companies
12.7 Regional Footprint
12.8 Competitive Scenario
13 Company Profiles
13.1 Major Players
13.1.1 Pfizer Inc.
13.1.1.1 Business Overview
13.1.1.2 Products Offered
13.1.1.3 Recent Developments
13.1.1.4 Analyst's View
13.1.1.4.1 Key Strengths/Right to Win
13.1.1.4.2 Strategic Choices
13.1.1.4.3 Weaknesses and Competitive Threats
13.1.2 Novartis International AG
13.1.2.1 Business Overview
13.1.2.2 Products Offered
13.1.2.3 Recent Developments
13.1.2.4 Analyst's View
13.1.2.4.1 Key Strengths/Right to Win
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses and Competitive Threats
13.1.3 Sanofi
13.1.3.1 Business Overview
13.1.3.2 Products Offered
13.1.3.3 Recent Developments
13.1.3.4 Analyst's View
13.1.3.4.1 Key Strengths/Right to Win
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses and Competitive Threats
13.1.4 F. Hoffmann-La Roche
13.1.4.1 Business Overview
13.1.4.2 Products Offered
13.1.4.3 Recent Developments
13.1.4.4 Analyst's View
13.1.4.4.1 Key Strengths/Right to Win
13.1.4.4.2 Strategic Choices
13.1.4.4.3 Weaknesses and Competitive Threats
13.1.5 Bristol-Myers Squibb Company
13.1.5.1 Business Overview
13.1.5.2 Products Offered
13.1.5.3 Recent Developments
13.1.5.4 Analyst's View
13.1.5.4.1 Key Strengths/Right to Win
13.1.5.4.2 Strategic Choices
13.1.5.4.3 Weaknesses and Competitive Threats
13.1.6 Boehringer-Ingelheim
13.1.6.1 Business Overview
13.1.6.2 Products Offered
13.1.6.3 Recent Developments
13.1.7 Teva Pharmaceutical Industry Ltd.
13.1.7.1 Business Overview
13.1.7.2 Products Offered
13.1.7.3 Recent Developments
13.1.8 Eli Lily and Company
13.1.8.1 Business Overview
13.1.8.2 Products Offered
13.1.8.3 Recent Developments
13.1.9 Merck & Co. Inc.
13.1.9.1 Business Overview
13.1.9.2 Products Offered
13.1.9.3 Recent Developments
13.1.10 AbbVie Inc.
13.1.10.1 Business Overview
13.1.10.2 Products Offered
13.1.11 Viatris Inc.
13.1.11.1 Business Overview
13.1.11.2 Products Offered
13.1.11.3 Recent Developments
13.1.12 Bayer
13.1.12.1 Business Overview
13.1.12.2 Products Offered
14 Appendix
14.1 Discussion Guide
14.2 Knowledge Store: The Subscription Portal
14.3 Available Customizations
List of Tables
Table 1 Pipeline of Oncology Drugs (2021)
Table 2 HPAPI Market: Porter's Five Forces Analysis
Table 3 HPAPI Market, by Type, 2020-2027 (USD Million)
Table 4 Innovative HPAPIs Market, by Region, 2020-2027 (USD Million)
Table 5 North America: Innovative HPAPIs Market, by Country, 2020-2027 (USD Million)
Table 6 Europe: Innovative HPAPIs Market, by Country, 2020-2027 (USD Million)
Table 7 Asia: Innovative HPAPIs Market, by Country, 2020-2027 (USD Million)
Table 8 Generic HPAPIs Market, by Region, 2020-2027 (USD Million)
Table 9 North America: Generic HPAPIs Market, by Country, 2020-2027 (USD Million)
Table 10 Europe: Generic HPAPIs Market, by Country, 2020-2027 (USD Million)
Table 11 Asia: Generic HPAPIs Market, by Country, 2020-2027 (USD Million)
Table 12 HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 13 Synthetic APIs Market, by Region, 2020-2027 (USD Million)
Table 14 North America: Synthetic APIs Market, by Country, 2020-2027 (USD Million)
Table 15 Europe: Synthetic APIs Market, by Country, 2020-2027 (USD Million)
Table 16 Asia: Synthetic APIs Market, by Country, 2020-2027 (USD Million)
Table 17 Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 18 Innovative Synthetic APIs
Table 19 Innovative Synthetic APIs Market, by Region, 2020-2027 (USD Million)
Table 20 North America: Innovative Synthetic APIs Market, by Country, 2020-2027 (USD Million)
Table 21 Europe: Innovative Synthetic Ap Market, by Country, 2020-2027 (USD Million)
Table 22 Asia: Innovative Synthetic APIs Market, by Country, 2020-2027 (USD Million)
Table 23 Generic Synthetic APIs
Table 24 Generic Synthetic APIs Market, by Region, 2020-2027 (USD Million)
Table 25 North America: Generic Synthetic APIs Market, by Country, 2020-2027 (USD Million)
Table 26 Europe: Generic Synthetic APIs Market, by Country, 2020-2027 (USD Million)
Table 27 Asia: Generic Synthetic APIs Market, by Country, 2020-2027 (USD Million)
Table 28 Biotech APIs Market, by Region, 2020-2027 (USD Million)
Table 29 North America: Biotech APIs Market, by Country, 2020-2027 (USD Million)
Table 30 Europe: Biotech APIs Market, by Country, 2020-2027 (USD Million)
Table 31 Asia: Biotech APIs Market, by Country, 2020-2027 (USD Million)
Table 32 Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 33 Innovative Biotech APIs
Table 34 Innovative Biotech APIs Market, by Region, 2020-2027 (USD Million)
Table 35 North America: Innovative Biotech APIs Market, by Country, 2020-2027 (USD Million)
Table 36 Europe: Innovative Biotech APIs Market, by Country, 2020-2027 (USD Million)
Table 37 Asia: Innovative Biotech APIs Market, by Country, 2020-2027 (USD Million)
Table 38 Biosimilars
Table 39 Biosimilars Market, by Region, 2020-2027 (USD Million)
Table 40 North America: Biosimilars Market, by Country, 2020-2027 (USD Million)
Table 41 Europe: Biosimilars Market, by Country, 2020-2027 (USD Million)
Table 42 Asia: Biosimilars Ingredients Market, by Country, 2020-2027 (USD Million)
Table 43 Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 44 Monoclonal Antibodies
Table 45 Monoclonal Antibodies Market, by Region, 2020-2027 (USD Million)
Table 46 Vaccines Market, by Region, 2020-2027 (USD Million)
Table 47 Recombinant Proteins Market, by Region, 2020-2027 (USD Million)
Table 48 HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 49 Captive HPAPI Manufacturers Market, by Region, 2020-2027 (USD Million)
Table 50 North America: Captive HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 51 Europe: Captive HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 52 Asia: Captive HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 53 Merchant HPAPI Manufacturers Market, by Region, 2020-2027 (USD Million)
Table 54 North America: Merchant HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 55 Europe: Merchant HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 56 Asia: Merchant HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 57 Global Merchant HPAPI Manufacturers Market, by Type, 2020-2027, (USD Million)
Table 58 Innovative Merchant HPAPI Manufacturers
Table 59 Innovative Merchant HPAPI Manufacturers Market, by Region, 2020-2027 (USD Million)
Table 60 North America: Innovative Merchant HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 61 Europe: Innovative Merchant HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 62 Asia: Innovative Merchant HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 63 Generic Merchant HPAPI Manufacturers
Table 64 Generic Merchant HPAPI Manufacturers Market, by Region, 2020-2027 (USD Million)
Table 65 North America: Generic Merchant HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 66 Europe: Generic Merchant HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 67 Asia: Generic Merchant HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 68 Merchant HPAPI Manufacturers Market, by Type of Synthesis, 2020-2027, (USD Million)
Table 69 Merchant Synthetic API Manufacturers Market, by Region, 2020-2027 (USD Million)
Table 70 North America: Merchant Synthetic API Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 71 Europe: Merchant Synthetic API Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 72 Asia: Merchant Synthetic API Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 73 Merchant Biotech API Manufacturers Market, by Region, 2020-2027 (USD Million)
Table 74 North America: Merchant Biotech API Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 75 Europe: Merchant Biotech HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 76 Asia: Merchant Biotech HPAPI Manufacturers Market, by Country, 2020-2027 (USD Million)
Table 77 HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 78 HPAPI Market for Oncology, by Region, 2020-2027 (USD Million)
Table 79 North America: HPAPI Market for Oncology, by Country, 2020-2027 (USD Million)
Table 80 Europe: HPAPI Market for Oncology, by Country, 2020-2027 (USD Million)
Table 81 Asia: HPAPI Market for Oncology, by Country, 2020-2027 (USD Million)
Table 82 HPAPI Market for Hormonal Imbalance, by Region, 2020-2027 (USD Million)
Table 83 North America: HPAPI Market for Hormonal Imbalance, by Country, 2020-2027 (USD Million)
Table 84 Europe: HPAPI Market for Hormonal Imbalance, by Country, 2020-2027 (USD Million)
Table 85 Asia: HPAPI Market for Hormonal Imbalance, by Country, 2020-2027 (USD Million)
Table 86 HPAPI Market for Glaucoma, by Region, 2020-2027 (USD Million)
Table 87 North America: HPAPI Market for Glaucoma, by Country, 2020-2027 (USD Million)
Table 88 Europe: HPAPI Market for Glaucoma, by Country, 2020-2027 (USD Million)
Table 89 Asia: HPAPI Market for Glaucoma, by Country, 2020-2027 (USD Million)
Table 90 HPAPI Market for Other Therapeutic Applications, by Region, 2020-2027 (USD Million)
Table 91 North America: HPAPI Market for Other Therapeutic Applications, by Country, 2020-2027 (USD Million)
Table 92 Europe: HPAPI Market for Other Therapeutic Applications, by Country, 2020-2027 (USD Million)
Table 93 Asia: HPAPI Market for Other Therapeutic Applications, by Country, 2020-2027 (USD Million)
Table 94 HPAPI Market, by Region, 2020-2027 (USD Million)
Table 95 North America: HPAPI Market, by Country, 2020-2027 (USD Million)
Table 96 North America: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 97 North America: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 98 North America: Merchant APIs Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 99 North America: Merchant APIs Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 100 North America: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 101 North America: Synthetic API Ingredients Market, by Type, 2020-2027 (USD Million)
Table 102 North America: Biotech HPAPI Market, by Type, 2020-2027 (USD Million)
Table 103 North America: Biotech HPAPI Market, by Product, 2020-2027 (USD Million)
Table 104 North America: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 105 US: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 106 US: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 107 US: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 108 US: Merchant HPAPI Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 109 US: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 110 US: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 111 US: Biotech APIs Market, by Type, 2020-2027 (USD Million
Table 112 US: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 113 US: High-Potency Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 114 Canada: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 115 Canada: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 116 Canada: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 117 Canada: Merchant API Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 118 Canada: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 119 Canada: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 120 Canada: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 121 Canada: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 122 Canada: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 123 Europe: HPAPI Market, by Country, 2020-2027 (USD Million)
Table 124 Europe: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 125 Europe: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 126 Europe: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 127 Europe: Merchant API Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 128 Europe: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 129 Europe: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 130 Europe: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 131 Europe: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 132 Europe: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 133 Germany: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 134 Germany: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 135 Germany: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 136 Germany: Merchant API Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 137 Germany: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 138 Germany: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 139 Germany: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 140 Germany: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 141 Germany: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 142 France: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 143 France: HPAPI Market, by Type of Manufacturer, (USD Million)
Table 144 France: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 145 France: Merchant HPAPI Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 146 France: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 147 France: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 148 France: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 149 France: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 150 France: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 151 UK: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 152 UK: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 153 UK: Merchant HPAPI Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 154 UK: Merchant HPAPI Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 155 UK: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 156 UK: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 157 UK: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 158 UK: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 159 UK: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 160 Italy: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 161 Italy: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 162 Italy: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 163 Italy: Merchant API Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 164 Italy: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 165 Italy: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 166 Italy: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 167 Italy: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 168 Italy: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 169 Spain: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 170 Spain: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 171 Spain: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 172 Spain: Merchant Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 173 Spain: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 174 Spain: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 175 Spain: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 176 Spain: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 177 Spain: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 178 Rest of Europe: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 179 Rest of Europe: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 180 Rest of Europe: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 181 Rest of Europe: Merchant Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 182 Rest of Europe: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 183 Rest of Europe: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 184 Rest of Europe: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 185 Rest of Europe: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 186 Rest of Europe: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 187 Asia: HPAPI Market, by Country, 2020-2027 (USD Million)
Table 188 Asia: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 189 Asia: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 190 Asia: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 191 Asia: Merchant API Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 192 Asia: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 193 Asia: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 194 Asia: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 195 Asia: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 196 Asia: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 197 Japan: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 198 Japan: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 199 Japan: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 200 Japan: Merchant HPAPI Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 201 Japan: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 202 Japan: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 203 Japan: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 204 Japan: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 205 Japan: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 206 China: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 207 China: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 208 China: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 209 China: Merchant API Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 210 China: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 211 China: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 212 China: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 213 China: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 214 China: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 215 India: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 216 India: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 217 India: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 218 India: Merchant API Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 219 India: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 220 India: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 221 India: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 222 India: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 223 India: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 224 Rest of Asia: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 225 Rest of Asia: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 226 Rest of Asia: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 227 Rest of Asia: Merchant API Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 228 Rest of Asia: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 229 Rest of Asia: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 230 Rest of Asia: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 231 Rest of Asia: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 232 Rest of Asia: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 233 RoW: HPAPI Market, by Type, 2020-2027 (USD Million)
Table 234 RoW: HPAPI Market, by Type of Manufacturer, 2020-2027 (USD Million)
Table 235 RoW: Merchant API Manufacturers Market, by Type, 2020-2027 (USD Million)
Table 236 RoW: Merchant API Manufacturers Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 237 RoW: HPAPI Market, by Type of Synthesis, 2020-2027 (USD Million)
Table 238 RoW: Synthetic APIs Market, by Type, 2020-2027 (USD Million)
Table 239 RoW: Biotech APIs Market, by Type, 2020-2027 (USD Million)
Table 240 RoW: Biotech APIs Market, by Product, 2020-2027 (USD Million)
Table 241 RoW: HPAPI Market, by Therapeutic Application, 2020-2027 (USD Million)
Table 242 HPAPI Market: Degree of Competition
Table 243 Portfolio Analysis by Type of Synthesis: HPAPI Market (2021)
Table 244 Portfolio Analysis by Type of Manufacturer: HPAPI Market (2021)
Table 245 Portfolio Analysis by Type of Therapeutic Applications: HPAPI Market (2021)
Table 246 Regional Footprint of Companies: HPAPI Market (2021)
Table 247 Product Launches
Table 248 Deals
Table 249 Pfizer Inc.: Business Overview
Table 250 Novartis International AG: Business Overview
Table 251 Sanofi: Business Overview
Table 252 F. Hoffmann-La Roche: Business Overview
Table 253 Bristol-Myers Squibb Company: Business Overview
Table 254 Boehringer-Ingelheim: Business Overview
Table 255 Teva Pharmaceutical Industry Ltd.: Business Overview
Table 256 Eli Lily and Company: Business Overview
Table 257 Merck & Co. Inc.: Business Overview
Table 258 AbbVie Inc.: Business Overview
Table 259 Viatris Inc.: Business Overview
Table 260 Bayer AG: Business Overview
List of Figures
Figure 1 HPAPI Market: Geographic Scope
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: HPAPI Market
Figure 4 Market Size Estimation: Bottom-Up Approach
Figure 5 Market Size Estimation: Top-Down Approach
Figure 6 HPAPI Market: CAGR Projections
Figure 7 Data Triangulation
Figure 8 HPAPI Market, by Type, 2021 vs. 2027
Figure 9 HPAPI Market, by Type of Manufacturer, 2021 vs. 2027
Figure 10 HPAPI Market, by Type of Synthesis, 2021 vs. 2027
Figure 11 HPAPI Market, by Therapeutic Application, 2021 vs. 2027
Figure 12 Geographic Snapshot of HPAPI Market (2018-2023)
Figure 13 Increasing Demand for Oncology Drugs and Antibody-Drug Conjugates to Drive Market Growth
Figure 14 Innovative HPAPIs to Dominate the Global Market in 2027
Figure 15 Synthetic HPAPIs to Dominate Market Share in 2021
Figure 16 Oncology Segment to Register Highest CAGR During Forecast Period
Figure 17 China & India to Register High Growth Rates During 2021-2027
Figure 18 HPAPI Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Innovative HPAPIs Segment to Dominate HPAPI Market
Figure 20 Synthetic Segment to Dominate Market in 2021
Figure 21 Captive HPAPI Manufacturers Segment to Account for Largest Market Share in 2021
Figure 22 Oncology Segment to Dominate HPAPI Market by Therapeutic Application
Figure 23 North America: HPAPI Market Snapshot
Figure 24 Europe: HPAPI Market Snapshot
Figure 25 Asia: HPAPI Market Snapshot
Figure 26 Rest of the World: HPAPI Market Snapshot
Figure 27 Key Developments in HPAPI Market, 2019-2022
Figure 28 HPAPI Market: Market Share Analysis, by Key Player, 2021
Figure 29 Revenue Share Analysis of Top Players in HPAPI Market, 2019-2021
Figure 30 HPAPI Market: Company Evaluation Quadrant
Figure 31 Pfizer Inc.: Company Snapshot (2021)
Figure 32 Novartis International AG: Company Snapshot (2021)
Figure 33 Sanofi: Company Snapshot (2021)
Figure 34 F. Hoffmann-La Roche: Company Snapshot (2021)
Figure 35 Bristol-Myers Squibb Company: Company Snapshot (2021)
Figure 36 Boehringer-Ingelheim: Company Snapshot (2021)
Figure 37 Teva Pharmaceutical Industry Ltd.: Company Snapshot (2021)
Figure 38 Eli Lily and Company: Company Snapshot (2021)
Figure 39 Merck & Co. Inc.: Company Snapshot (2021)
Figure 40 AbbVie Inc.: Company Snapshot (2021)
Figure 41 Viatris Inc.: Company Snapshot (2021)
Figure 42 Bayer AG: Company Snapshot (2021)

Executive Summary

Companies Mentioned

  • AbbVie Inc.
  • Bayer
  • Boehringer-Ingelheim
  • Bristol-Myers Squibb Company
  • Eli Lily and Company
  • F. Hoffmann-La Roche
  • Merck & Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industry Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...